Involvement of cellular and enzymatic aspects in the complexity of diabetic neuropathy.
Level 5 - mechanism / opinion, no new human data
Narrative review of molecular and cellular mechanisms without original empirical data or systematic search methodology.
PubMed 41170890 · doi:10.1080/21688370.2025.2581880
What was done
This narrative review synthesized literature on the cellular and enzymatic mechanisms involved in the development and progression of diabetic neuropathy, focusing on chronic hyperglycemia-induced pathways, cellular interactions among neurons, glial, and immune cells, and potential therapeutic targets.
What was found
The abstract reports no quantitative data or numbers. It qualitatively outlines key enzymatic pathways involved in diabetic neuropathy, including aldose reductase, protein kinase C, poly(ADP-ribose) polymerase, and endogenous antioxidants, alongside regulatory factors like AMPK, NGF, IGF-1, and VEGF.
Why it matters
It organizes the complex cellular and enzymatic crosstalk underlying diabetic neuropathy to highlight potential disease-modifying targets beyond symptomatic management.
Limits
As a narrative review, it presents no original experimental data, quantitative effect sizes, or systematic search protocols. Human clinical efficacy for the discussed targets is not evaluated in the abstract.
Cited by
- supports Activation of the polyol pathway by glucose, along with elevated sodium and hypoxia, contributes to acquired mitochondrial dysfunction.